Patents by Inventor Peter M. Hobart

Peter M. Hobart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Plasmids suitable for IL-2 expression
    Publication number: 20030203863
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Application
    Filed: April 23, 2002
    Publication date: October 30, 2003
    Applicant: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi
  • Cancer treatment method utilizing plasmids suitable for IL-2 expression
    Patent number: 6399588
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: June 4, 2002
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi
  • Cancer treatment method utilizing plasmids suitable for IL-2 expression
    Patent number: 6147055
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Grant
    Filed: March 14, 1997
    Date of Patent: November 14, 2000
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi
  • Tetracycline inducible/repressible systems
    Patent number: 5891718
    Abstract: This application relates to effector controlled eukaryotic expression vectors adapted for use in gene therapy or gene immunization having positive feedback regulation.
    Type: Grant
    Filed: March 27, 1996
    Date of Patent: April 6, 1999
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Xiaowu Liang
  • Plasmids suitable for IL-2 expression
    Patent number: 5641665
    Abstract: The present invention relates to plasmids suitable for IL-2 expression, particularly, human IL-2 expression, and related methods.
    Type: Grant
    Filed: November 28, 1994
    Date of Patent: June 24, 1997
    Assignee: Vical Incorporated
    Inventors: Peter M. Hobart, Michal Margalith, Suezanne E. Parker, Shirin Khatibi